FI945697A - Menetelmä heikennetyn varicella Zoster -virusrokotteen valmistamiseksi - Google Patents

Menetelmä heikennetyn varicella Zoster -virusrokotteen valmistamiseksi Download PDF

Info

Publication number
FI945697A
FI945697A FI945697A FI945697A FI945697A FI 945697 A FI945697 A FI 945697A FI 945697 A FI945697 A FI 945697A FI 945697 A FI945697 A FI 945697A FI 945697 A FI945697 A FI 945697A
Authority
FI
Finland
Prior art keywords
medium
preparing
virus vaccine
zoster virus
varicella zoster
Prior art date
Application number
FI945697A
Other languages
English (en)
Swedish (sv)
Other versions
FI117758B (fi
FI945697A0 (fi
Inventor
Philip J Provost
David L Krah
Paul A Friedman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/893,295 external-priority patent/US5360736A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI945697A0 publication Critical patent/FI945697A0/fi
Publication of FI945697A publication Critical patent/FI945697A/fi
Application granted granted Critical
Publication of FI117758B publication Critical patent/FI117758B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI945697A 1992-06-04 1994-12-02 Menetelmä heikennettyä varicella zoster -virusta sisältävän rokotteen tuottamiseksi FI117758B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US89403992A 1992-06-04 1992-06-04
US89403992 1992-06-04
US89329592 1992-06-04
US07/893,295 US5360736A (en) 1992-06-04 1992-06-04 Process for attenuated varicella zoster virus vaccine production
US9304986 1993-05-26
PCT/US1993/004986 WO1993024616A1 (en) 1992-06-04 1993-05-26 Process for attenuated varicella zoster virus vaccine production

Publications (3)

Publication Number Publication Date
FI945697A0 FI945697A0 (fi) 1994-12-02
FI945697A true FI945697A (fi) 1995-01-26
FI117758B FI117758B (fi) 2007-02-15

Family

ID=27129046

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945697A FI117758B (fi) 1992-06-04 1994-12-02 Menetelmä heikennettyä varicella zoster -virusta sisältävän rokotteen tuottamiseksi

Country Status (28)

Country Link
US (1) US5607852A (fi)
EP (2) EP1097988B1 (fi)
JP (2) JP2599552B2 (fi)
KR (1) KR100350169B1 (fi)
CN (2) CN1069216C (fi)
AT (2) ATE419332T1 (fi)
AU (2) AU4392193A (fi)
BG (1) BG62176B1 (fi)
CA (1) CA2097019C (fi)
CZ (2) CZ289574B6 (fi)
DE (2) DE69330850T2 (fi)
DK (2) DK1097988T3 (fi)
ES (2) ES2317869T3 (fi)
FI (1) FI117758B (fi)
GR (1) GR3036812T3 (fi)
HU (1) HU220080B (fi)
MX (1) MX9303274A (fi)
NO (1) NO314068B1 (fi)
NZ (1) NZ253527A (fi)
PT (2) PT573107E (fi)
RO (1) RO114906B1 (fi)
RS (1) RS50330B (fi)
RU (1) RU2126269C1 (fi)
SK (1) SK279387B6 (fi)
TW (1) TW349868B (fi)
UA (1) UA27137C2 (fi)
WO (1) WO1993024616A1 (fi)
YU (1) YU49210B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2361495A (en) 1994-04-28 1995-11-29 Aviron A novel vzv gene, mutant vzv and immunogenic compositions
KR0177323B1 (ko) * 1996-02-16 1999-04-01 성재갑 바이러스 백신 생산에 유용한 사람 이배체 폐세포 및 이를 이용한 수두 백신의 제조방법
US20040171152A1 (en) * 1996-10-10 2004-09-02 Invitrogen Corporation Animal cell culture media comprising non-animal or plant-derived nutrients
DE69738806D1 (de) * 1996-10-10 2008-08-14 Invitrogen Corp Tierzellkulturmedium mit pflanzlichen nährstoffen
GB9716611D0 (en) * 1997-08-07 1997-10-08 Cantab Pharmaceuticals Res Ltd Virus preparations and methods
US6210683B1 (en) 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
GB9804632D0 (en) 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
KR100378909B1 (ko) * 1998-03-18 2003-12-18 주식회사 엘지생명과학 사람세포주를이용한풍진백신의생산수율증대방법
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
WO1999057246A1 (en) * 1998-05-01 1999-11-11 Life Technologies, Inc. Animal cell culture media comprising non-animal or plant-derived nutrients
US20060286668A1 (en) * 1999-04-30 2006-12-21 Invitrogen Corporation Animal-cell culture media comprising non-animal or plant-derived nutrients
CA2359659C (en) * 2000-01-31 2006-10-17 The Research Foundation For Microbial Diseases Of Osaka University Method for quality control of an attenuated varicella live vaccine
CN1318580C (zh) * 2003-07-10 2007-05-30 北京科兴生物制品有限公司 可满足灭活疫苗生产的sars病毒规模化制备及灭活的方法
US7344839B2 (en) * 2004-12-23 2008-03-18 Aurx, Inc. Virus preparations and methods
US20100184190A1 (en) * 2006-10-17 2010-07-22 Medimmune, Llc Influencing viral lipid constituents
US20080294361A1 (en) * 2007-05-24 2008-11-27 Popp Shane M Intelligent execution system for the monitoring and execution of vaccine manufacturing
EP2310495B1 (en) * 2008-08-11 2017-11-22 Sanofi Pasteur Biologics, LLC Compositions and methods for the production of alpha-herpesvirus 2
CN101967466A (zh) * 2009-07-28 2011-02-09 新泽西医学院 Orf7缺陷型水痘病毒株、含有该毒株的疫苗及其应用
FR2952825B1 (fr) 2009-11-24 2012-05-25 Goaster Jacqueline Le Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2
CN101972474B (zh) * 2010-11-11 2012-06-27 长春祈健生物制品有限公司 冻干带状疱疹减毒活疫苗及制备方法
US20140147458A1 (en) * 2011-02-24 2014-05-29 Mogam Biotechnology Research Institute Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same
WO2014062060A1 (en) * 2012-10-18 2014-04-24 Erasmus University Medical Center Rotterdam New method for producing high titer cell-free vzv vaccine virus
CN103074304B (zh) * 2013-01-28 2016-01-13 江苏健安生物科技有限公司 高水平人二倍体细胞培养水痘-带状疱疹疫苗病毒方法
US10350289B2 (en) 2013-09-05 2019-07-16 Merck Sharp & Dohme Corp. Methods of immunization with varicella zoster virus antigen
CN103740735B (zh) * 2013-12-31 2016-04-06 李越希 化学合成的HSV2病毒gC糖蛋白胞外区基因片段及其表达、应用
JP6655618B2 (ja) * 2014-12-01 2020-02-26 トランジェーヌＴｒａｎｓｇｅｎｅ 安定な液体ワクシニアウイルス処方物
RU2637093C1 (ru) * 2016-12-20 2017-11-29 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) Способ получения живой культуральной аттенуированной вакцины для профилактики ветряной оспы
CN107174658B (zh) * 2017-04-29 2020-11-27 安徽智飞龙科马生物制药有限公司 人用水痘病毒灭活疫苗及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660565A (en) * 1968-04-17 1972-05-02 Wistar Inst Rubella vaccine and method
US3555149A (en) * 1968-07-05 1971-01-12 Merck & Co Inc Mumps vaccine and its preparation
US3919411A (en) * 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
JPS5341202B2 (fi) * 1974-03-12 1978-11-01
US3961046A (en) * 1974-12-02 1976-06-01 American Cyanamid Company Mumps vaccine and preparation thereof
US4000256A (en) * 1975-04-30 1976-12-28 Merck & Co., Inc. Varicella vaccine and process for its preparation
GB1481650A (en) * 1975-05-06 1977-08-03 Merck & Co Inc Chemical processes and products
JPS5251009A (en) * 1975-10-17 1977-04-23 Morinaga Milk Ind Co Ltd Method of producing drug for treating marrow leukemia
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
JPS5341202A (en) * 1976-09-28 1978-04-14 Fuji Photo Film Co Ltd Novel magnetic recording medium
JPS55147227A (en) * 1979-05-04 1980-11-17 Handai Biseibutsubiyou Kenkyukai Preparrtion of attenuated live mumps vaccine
US4252792A (en) * 1979-09-21 1981-02-24 Douglas Industries, Inc. Injectable rabies vaccine composition and method for preparing same
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
JPS624370A (ja) * 1985-07-01 1987-01-10 Sharp Corp 半導体素子
US5024836A (en) * 1987-05-04 1991-06-18 Merck & Co., Inc. Stable lyophilized live herpes virus vaccine
WO1990003429A1 (en) * 1988-09-23 1990-04-05 Cetus Corporation Lipid microemulsions for culture media
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production

Also Published As

Publication number Publication date
YU49210B (sh) 2004-09-03
RS50330B (sr) 2009-11-10
KR100350169B1 (ko) 2004-05-20
SK279387B6 (sk) 1998-10-07
YU7504A (sh) 2006-08-17
WO1993024616A1 (en) 1993-12-09
ES2317869T3 (es) 2009-05-01
ES2161702T3 (es) 2001-12-16
HU9403473D0 (en) 1995-02-28
EP0573107A2 (en) 1993-12-08
PT1097988E (pt) 2009-03-05
US5607852A (en) 1997-03-04
NO944654D0 (no) 1994-12-02
EP0573107B1 (en) 2001-10-04
JPH09107958A (ja) 1997-04-28
NO314068B1 (no) 2003-01-27
CZ304594A3 (en) 1995-10-18
EP1097988A1 (en) 2001-05-09
PT573107E (pt) 2002-02-28
CZ289690B6 (cs) 2002-03-13
BG99227A (bg) 1995-07-28
CN1307902A (zh) 2001-08-15
CA2097019A1 (en) 1993-12-05
AU673167B2 (en) 1996-10-31
YU38893A (sh) 1996-02-19
AU4003693A (en) 1993-12-09
TW349868B (en) 1999-01-11
ATE206311T1 (de) 2001-10-15
AU4392193A (en) 1993-12-30
DE69330850T2 (de) 2002-04-11
DE69334254D1 (de) 2009-02-12
HU220080B (hu) 2001-10-28
EP1097988B1 (en) 2008-12-31
RU2126269C1 (ru) 1999-02-20
BG62176B1 (bg) 1999-04-30
CN1082923A (zh) 1994-03-02
JPH06172215A (ja) 1994-06-21
NZ253527A (en) 1996-09-25
JP2599552B2 (ja) 1997-04-09
GR3036812T3 (en) 2002-01-31
DE69330850D1 (de) 2001-11-08
JP3156962B2 (ja) 2001-04-16
CZ289574B6 (cs) 2002-02-13
HUT71863A (en) 1996-02-28
MX9303274A (es) 1994-01-31
SK148094A3 (en) 1995-07-11
DK1097988T3 (da) 2009-05-04
DK0573107T3 (da) 2001-11-12
CN1069216C (zh) 2001-08-08
FI117758B (fi) 2007-02-15
RO114906B1 (ro) 1999-08-30
ATE419332T1 (de) 2009-01-15
UA27137C2 (uk) 2000-02-28
NO944654L (no) 1995-02-03
EP0573107A3 (en) 1995-04-26
CA2097019C (en) 2007-07-24
FI945697A0 (fi) 1994-12-02

Similar Documents

Publication Publication Date Title
FI945697A (fi) Menetelmä heikennetyn varicella Zoster -virusrokotteen valmistamiseksi
DE69637656D1 (de) Methoden zur Züchtung von Tierzellen
NO922887L (no) Fremgangsmaate for dannelse av cellemasse og/eller fermenteringsprodukter under sterile forhold samt anordning for utfoerelse av fremgangsmaaten
ES8505818A1 (es) Un metodo para la produccion de una fraccion ha que contiene antigenos protectores de bordetella pertussis
DE3681811D1 (de) Verfahren zur kontinuierlichen herstellung von l-carnitin.
US4169761A (en) Process for the cultivation of viruses
DE69821343D1 (de) Verfahren zur steigerung des wachstums von pflanzenzellkulturen
Douglas Uric acid utilization in Platymonas convolutae and symbiotic Convoluta roscoffensis
EP0276154A3 (en) Method and apparatus for cell culture
KR920012425A (ko) 동물세포 배양용 고농도 배지 및 배양공정
EP0987324A3 (en) Cell growth accelerator containing polyphosphoric acid and cell growth method using the same
JPS5933353B2 (ja) クロレラの培養法
JPS5668395A (en) Production of d(-)-beta-hydroxyisobutyric acid
EP0263659A3 (en) Tissue culture media containing l-carnitine
RU93048367A (ru) Способ получения шиконина-5,8-дигидрокси-3-/1-гидрокси-4-метил-3-пентил/-1,4-нафтохинона
RU2001123409A (ru) Способ культивирования микроорганизмов Mycobacterium tuberculosis

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117758

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

Free format text: MERCK SHARP & DOHME CORP.

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

MA Patent expired